Innovative Therapies
for Skin Diseases
We are building a premier medical dermatology company focused on developing and commercializing innovative therapeutic products for
skin diseases.
ABOUT US
Innovative Therapies for
Skin Diseases
We are building a premier medical dermatology company focused on developing and commercializing innovative therapeutic products for skin diseases.
ABOUT US
Your Skin Health
What is Skin?
Molluscum Contagiosum
Molluscum is a common, contagious skin infection that primarily affects children below the age of 14.1
Rosacea
It is estimated that approximately 16 million Americans suffer from rosacea2 which is a chronic but treatable skin condition that primarily affects the central face and is often characterized by flare-ups and remissions.
Plaque Psoriasis
Psoriasis is a common, non-contagious, chronic skin disease, with no clear cause or cure and affects approximately 2-3% of the population. 3
Acne
Acne (acne vulgaris) is a common chronic skin condition affecting up to 50 million people in the United States annually.4 It usually begins in puberty with approximately 85 percent of people between the ages of 12 and 24.4,5
1. Prevalence in the US of 5.1%-11.5% in children aged 0-14. (Fam Pract. 2014 Apr;31(2):130-6) 2.https://www.rosacea.org/patients/information 3. https://www.psoriasis.org/psoriasis-statistics/ 4. Bickers DR, et al. Journal of the American Academy of Dermatology 2006;55:490-500 5. Bhate K, Williams HC. The British journal of dermatology 2013;168:474-85
Research and Development
We are leveraging our leading nitric oxide-based technology platform and clinical development expertise to bring new safe and efficacious therapies to people in need.
Learn More
We are leveraging our leading nitric oxide-based technology platform and clinical development expertise to bring new safe and efficacious therapies to people in need.
Learn More
Leveraging leading nitric oxide-based science, technology and clinical translation in support of delivering safe and efficacious therapies.